ChristineAPratilasMD
Pediatric Hematology & Oncology • Baltimore, MDPediatric Sarcoma Oncology
Associate Professor of Oncology and Pediatrics, Johns Hopkins University School of Medicine
Dr. Pratilas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1650 Orleans St
Cancer Res Bldg 1
Baltimore, MD 21287Phone+1 443-287-8623Fax+1 410-502-7223
Summary
- Dr. Christine Pratilas is a specialist in Pediatric Hematology & Oncology based in Baltimore, MD, with a subspecialty in Pediatric Sarcoma Oncology. She completed her pediatrics residency at Rutgers Health and her fellowship in Pediatric Hematology/Oncology at New York Presbyterian Hospital. Currently, she is an Associate Professor at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and served as an Attending Physician at Memorial Sloan Kettering Cancer Center from 2006 to 2014. Her expertise includes neurofibromatosis type I and cancers such as osteosarcoma and Ewing sarcoma. She has authored several publications focusing on pediatric oncology and is involved in clinical trials such as the Pediatric MATCH Treatment Trial.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2002 - 2005
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Pediatrics, 1999 - 2002
Rutgers Robert Wood Johnson Medical SchoolClass of 1999
Certifications & Licensure
PA State Medical License 2024 - 2026
MD State Medical License 2014 - 2025
NY State Medical License 2002 - 2015
NJ State Medical License 2000 - 2003
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial Start of enrollment: 2020 Oct 13
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Roles: Contact
Publications & Presentations
PubMed
- DLK1 distinguishes subsets of NF1-associated malignant peripheral nerve sheath tumors with divergent molecular signatures.Dana K Mitchell, Kylee Brewster, Stavriani C Makri, Jaffar Khan, Eric A Albright
Clinical Cancer Research. 2025-03-10 - Impact of Hospital Volume on Survival for Pediatric Wilms Tumor.Charbel Chidiac, Olivia Liu, Paul Phan, Elizabeth Khvatova, Christine A Pratilas
Pediatric Blood & Cancer. 2025-03-01 - Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat.Erin E Resch, Stavriani C Makri, Paola Ghanem, Ezra G Baraban, Kenneth J Cohen
NPJ Precision Oncology. 2025-02-21
Press Mentions
- The Children’s Cancer Foundation, Inc. Announces the 2023 CCF Research AwardsJuly 27th, 2023
Grant Support
- Advancing RAS pathway targeted therapy in NF1-MPNST: effects of SHP2 and CDK4/6 inhibitors on the tumor and the tumor immune microenvironmentJOHNS HOPKINS UNIVERSITY2023–2028
- Feedback Regulation And Functional Output Of The Ras/Raf/Mek/Mapk Pathway In HumaNational Cancer Institute2009–2011
Professional Memberships
- Member
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/christine-pratilas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
